Lowering Iron Levels in Brain May Help Treat Parkinson’s, Trial in People with PKAN Says
Binding to, or chelating, toxic levels of iron in the brain can slow the progression of a neurodegenerative disorder known…
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Binding to, or chelating, toxic levels of iron in the brain can slow the progression of a neurodegenerative disorder known…
The formation of alpha-synuclein aggregates in brain nerve cells (neurons) is thought to be one of the hallmarks of Parkinson…
The U.S. Food and Drug Administration (FDA) has approved a generic equivalent to Sinemet (carbidopa/levodopa) for the…
Measuring the electric brain activity of people with Parkinson’s may be a non-invasive and accurate way of diagnosing the disease…
Mutations in the LRRK2 gene, which have been linked to familial Parkinson’s disease, impair the activity of the…
Mindfulness-based interventions can improve mental health status, including reduction of stress and anxiety levels, in family caregivers of veterans with…
A single-dose infusion of VY-AADC01, an investigational gene therapy, improves motor function and reduces the need for antiparkinsonian medications in…
Understanding and identifying epigenetic changes may become a potential strategy for early Parkinson’s diagnosis, when patients still lack the characteristic symptoms…
A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal…
A project to identify new genes involved in the development of Parkinson’s disease has received $1 million in funding from…
Get regular updates to your inbox.